This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.
18 - 39 years old
Able to speak/read English
Completed primary cancer treatment (e.g., surgery, radiation, chemotherapy, immunotherapy) at least one month prior to the time of consent. Although, participants will be eligible if they are receiving maintenance treatments
Report at least one moderate to severe symptom, side effect, or supportive care concern from cancer or its treatment
Completed cancer treatment more than three years ago
Single group
Artificial Intelligence-based Intervention
Other interventionInteract with AI-powered supportive care chatbot
Interview
Other interventionAncillary studies
Survey Administration
Other interventionAncillary studies
Acceptability of AI-powered supportive care chatbot
Acceptability will be supported if mean scores on the Acceptability E-Scale are ≥ 4 (on a 5-point scale). Will be described (i.e., means, medians, standard deviations, and ranges) at the post-intervention time point.
Demand of AI-powered supportive care chatbot
Demand will be demonstrated by successful recruitment of the target sample (N=30) within 12 months.
Implementation of AI-powered supportive care chatbot
Implementation will be assessed by engagement with the chatbot, defined as ≥ 70% of participants reporting at least one use per week during the initial 4-week period, rather than a fixed duration of use, given the self-directed nature of the intervention. Will be described (i.e., means, medians, standard deviations, and ranges) weekly. Given the pilot nature of the study, no hypothesis testing or formal comparisons will be conducted.
Retention
Retention will be considered feasible if ≥ 80% of participants complete 4-week assessments, and ≥ 50% elect to continue to the optional extended use period.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
